Padagis US recalls
Padagis US has 8 recalls on record with the FDA and USDA, the earliest in 2022 and the latest reported on 22 Jul 2026. 4 are still ongoing. 1 was reported in the last 12 months. The most frequent reason is potency & assay.
Total recalls8since 2022
Last 12 months1reported
Class I00% of total
Ongoing4latest 22 Jul 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 6 75%Class III 2 25%
Why padagis us is recalled
Product types
Brands
By year
Ongoing padagis us recalls
4 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Nystatin Cream USP, (100,000 USP Nystatin Units) recalled by Padagis USNystatin | Padagis US | Potency & Assay | Nationwide |
| Drug | CLASS II | Trospium Chloride Extended-Release Capsules, 60 mg recalledTrospium Chloride | Padagis US | Other | Nationwide |
| Drug | CLASS II | Gynazole-1, (Butoconazole Nitrate) Vaginal Cream recalled by Padagis USGynazole 1 | Padagis US | Packaging Defects | Nationwide |
| Drug | CLASS III | Evamist (estradiol transdermal spray) recalled by Padagis USEvamist | Padagis US | Potency & Assay | Nationwide |
All padagis us recalls, newest first
8 totalAbout this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.